CHAPTER / ANSWERS
Five myths worth clearing up early
Short answers to the claims that make peptide care sound simpler than it is.
MYTH
Peptide is a seal of quality.
FACT
“Peptide” only says what a substance is made of: a short chain of the building blocks of protein. It says nothing about quality, a licence, or approval.
The category is broad. The exact product is what matters.
Approved and compounded are not synonyms
MYTH
A pharmacy-made medicine has passed the same review as an approved drug.
FACT
As of September 2026, a compounded medicine goes on sale without FDA approval and without FDA first reviewing its safety, how well it works, or its quality.
CONTEXT
Compounding can meet a patient need that a ready-made product cannot meet.
Online does not mean outside the rules
MYTH
A clinician can prescribe from any state because the visit is on a screen.
FACT
As of September 2026, Virginia generally treats care as happening where the patient is located.
CHECK
As of September 2026, the clinician’s Virginia authority belongs in the state licence record.
Research labels do not make a treatment route
MYTH
A “research use only” line makes an injectable product legitimate for personal treatment.
FACT
As of September 2026, FDA warning letters say that when a seller’s page suggests people take the product themselves, or sells injection supplies with it, FDA treats it as a drug sold for people.
CHECK
Look at what the page claims and what comes with the product, not only the disclaimer.
ENDNOTES / THIS CHAPTER